Intima Bioscience: Data from first-in-human trial targeting CISH in patients with metastatic colorectal cancer
Administered CRISPR genetically engineered CISH-knockout Tumor Infiltrating Lymphocytes as a Model System to Evaluate the Safety and Efficacy of this Classically Undruggable Intracellular Target...